Searched for
US REGULATIONS IMPACT ON INDIAN PHARMA
French president urges US to share cutting-edge AI and democracies to cooperate on regulationFrench President Macron urged wealthy democracies to unite on AI regulation, a sentiment echoed by OpenAI's CEO. Amidst US restrictions on ...- Sensex rises 254 points, Nifty closes above 24,150; IndiGo, Trent among top gainersIndian stock markets closed higher on Thursday, with Sensex and Nifty extending gains for a fifth consecutive session. Despite a hawkish US...
- Agentic AI adoption drives stronger governance oversight, risk controlsIndia first: Firms prioritise domestic industry guidelines over global frameworks, remain confident on DPDP
- The onshore gateway to global capitalIndia's economy is set to grow significantly, but its global market presence lags. GIFT IFSC is building infrastructure to bridge this gap....
- We cannot let AI frontier models fall into hands of authoritarian regimes: French President Emmanuel MacronArtificial intelligence frontier models must not be allowed to fall into the hands of authoritarian regimes, but democracies must co-ope...
- G7 leaders vow closer ties on AI as they hash out 'trusted partners' schemeG7 leaders are coordinating on advanced AI risks and opportunities. They are discussing a "trusted partners" scheme to grant non-US nations...
- Stocks in news: Prime Focus, Groww, GIC RE, Wipro, NykaaIndian benchmark indices traded with a positive bias, with the Nifty consolidating near the 24,000 mark and closing near its day's high. Se...
- India has wide AI talent gaps in deployment, governance, security: Quess reportIndia faces significant AI talent gaps in deployment, governance, and security roles, with GenAI deployment showing the widest deficit. Whi...
- NCDEX launches 'Har Ghar Investor' campaignNCDEX Ltd has launched its nationwide 'HarGhar Investor' campaign in Guwahati, aiming to bring every Indian household into formal, regulate...
- AI in Hungary could unlock productivity gains of €15 billion: McKinseyMcKinsey projects AI could boost Hungary's productivity by €15 billion by 2030, helping close the gap with European neighbours. However, la...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- Rupee inches up, Iran deal longevity worries and hedging dragThe Indian rupee saw a modest rise against the U.S. dollar, influenced by a U.S.-Iran truce but tempered by importer hedging and skepticism...
- Musk's Starlink may face curbs on satellite data routing in IndiaIndia is reviewing Starlink's satellite internet plans. The government is concerned about data crossing borders via laser-linked satellites...
- Agentic AI adoption drives stronger governance oversight, risk controlsIndian companies are prioritising local AI rules over international ones. They are focusing on ethics, identity, and privacy as AI adoption...
- 'Not a great environment for Indian market': Harsha Upadhyaya on Iran-US tensions, IT outlook, pharma bet, and where to be cautiousGlobal challenges are impacting Indian stocks. West Asian tensions and rising US inflation create headwinds. Tech sector shifts also affect...
- Regulators tighten GMP oversight of pharma plantsSeveral states have constituted dedicated multi-member teams to ensure no facility slips through the cracks before a GMP Certificate is iss...
- Japanese investors are looking beyond China... India is key alternative: Tsutomu Takemura, Senior MD, NomuraIndia is increasingly becoming a long-term structural investment destination rather than a short-term strategic bet. Global capital is movi...
- US drug regulator issues import alert for drugs made at a Dabur India plantThe US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed si...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- India willing to open its market to high-quality, innovative pharma products, says commerce ministerIndia is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...
Load More
